FLAG PROTOCOL-BASED CURE RATE OF ACUTE MYELOID LEUKEMIA
https://doi.org/10.51523/2708-6011.2011-8-2s-30
Abstract
The article presents the results of our own fludarabin-containing FLAG protocol-based treatment of 54 patients with both first detected and resistant forms of acute myeloid leukemia. It has been shown that, the application of the indicated chemiotherapy scheme is highly effective and makes it possible to assure remission in most patients.
About the Authors
N. N. Tretyak
Institute of Haematology and Transfusiology AMS Ukraine
Belarus
Belarus
N. V. Goryainova
Institute of Haematology and Transfusiology AMS Ukraine
Belarus
Belarus
E. A. Kiseliova
Institute of Haematology and Transfusiology AMS Ukraine
Belarus
Belarus
A. I. Koval
Institute of Haematology and Transfusiology AMS Ukraine
Belarus
Belarus
M. Yu. Anoshina
Institute of Haematology and Transfusiology AMS Ukraine
Belarus
Belarus
O. V. Basova
Institute of Haematology and Transfusiology AMS Ukraine
Belarus
Belarus
A. M. Vakulchuk
Institute of Haematology and Transfusiology AMS Ukraine
Belarus
Belarus
T. P. Perehrestenko
Institute of Haematology and Transfusiology AMS Ukraine
Belarus
Belarus
V. N. Mnishenko
Institute of Haematology and Transfusiology AMS Ukraine
Belarus
Belarus
References
1. БИБЛИОГРАФИЧЕСКИЙ СПИСОК
2. Pharmacokinetics and pharmacodynamics studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusion / V. I. Avramis [et al.] // The Children Cancer Group. Clin. Cancer Res. - 1998. - Vol. 4(1). - P. 45-52.
3. Cortes, J. E. Defining the optimal dose schedule of purine analogs and assessment of response / J. E. Cortes, S. M. O’Brien; ed.: B. D. Cheson [et al.]. // Nucleoside analogs in cancer therapy. - New York: Marcel. Dekker. Inc. - 1997. - P. 175-200.
4. Gandhi, V. Cellular and clinical pharmacology of fludarabine / V. Gandhi, W. Plunkett // Clin. Pharmacokinet. - 2002. - Vol. 41. - P. 93-103.
5. Combination of fludarabine and arabinosylcytosine for the treatment of chronic lymphocytic leukemia: clinical efficacy and modulation of arabinosylcytosine pharmacology / V. Gandhi [et al.] // Cancer Chem. Pharmacol. - 1994. - Vol. 34. - P. 30-36.
6. Grant, S. Ara-C: cellular and molecular pharmacology / S. Grant // Adv. Cancer Res. - 1998. - Vol. 72. - P. 197-233.
7. Fludarabine in low-grade lymphoma / A. Pigaditou [et al.] // Semin. Oncol. - 1993. - Vol. 20, № 7. - P. 24-27.
8. Plunkett, W. Metabolism and action of fludarabine phosphate / W. Plunkett, P. Huang, V. Gandhi // Semin. Oncol. - 1990. - Vol. 17, № 8. - Р. 3-17.
9. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'-deoxyadenosine and 9-D-arabinosyl-2-fluoroadenine / L. E. Robertson [et al.] // Blood. - 1993. - Vol. 81. - P. 143-150.
10. Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemia / L. E. Robertson [et al.] // Leukemia. - 1995. - Vol. 9. - P. 943-945.
11. Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: а German multicenter phase II study / M. J. Rummel [et al.] // Ann. Oncol. - 1999. - Vol. 10. - P. 183-188.
Review
For citations:
Tretyak N.N., Goryainova N.V., Kiseliova E.A., Koval A.I., Anoshina M.Yu., Basova O.V., Vakulchuk A.M., Perehrestenko T.P., Mnishenko V.N. FLAG PROTOCOL-BASED CURE RATE OF ACUTE MYELOID LEUKEMIA. Health and Ecology Issues. 2011;(2S):85-87. (In Russ.) https://doi.org/10.51523/2708-6011.2011-8-2s-30
Views: 287
Email this article 